Riyadh biotech summit to draw 100-plus speakers from 70 countries

Saudi Arabia will host the 4th Riyadh Global Medical Biotechnology Summit in Riyadh from Sept. 14-16, 2026, bringing together scientists, investors, policymakers and health innovators. Organizers say the event is meant to advance the kingdom’s biotech strategy and position the country as a regional and global hub for innovation, investment and talent.

Why it matters: - The summit is tied to Saudi Arabia’s National Biotechnology Strategy, which aims to generate $34.6 billion in non-oil GDP from biotechnology by 2040. - The event is designed to connect research, regulation, manufacturing and investment across the biotech value chain. - Organizers say the summit supports Saudi Arabia’s push to become a regional and global center for biotech innovation, investment and talent.

What happened: - The 4th Riyadh Global Medical Biotechnology Summit will take place in Riyadh, Saudi Arabia, from Sept. 14-16, 2026. - The event will bring together scientists, investors, policymakers and healthcare innovators across six themes: AI in biotechnology, multi-omics and localization, biotech investment, immunology, bioengineering and synthetic biology, and workforce development. - Organizers expect more than 15,000 visitors, more than 100 local and international speakers, 200 biotech and healthcare brands, and more than 80 exhibiting entities from government and industry. - Delegations from more than 70 countries are expected to attend. - The summit aims to see more than 65 deals and memorandums of understanding signed over three days. - Registration is open for delegates, exhibitors and industry partners, with program details available at rgmbs.org.

The details: - The scientific program spans the full biomedicine innovation pathway, from population genomics and AI-driven drug discovery to local biomanufacturing, regulatory science, commercialization and investment. - The program includes public genomic initiatives, local bio-manufacturing, cGMP production and digital platforms meant to speed discovery and turn research into practical solutions. - The summit is held under the supervision of the Ministry of National Guard, through its Health Affairs sector. - King Abdullah International Medical Research Center and King Saud bin Abdulaziz University for Health Sciences are hosting the event. - The Ministry of Investment, Invest Saudi and the Saudi Data and Artificial Intelligence Authority are strategic partners. - The summit will feature scientific sessions, panel discussions, workshops and signing ceremonies. - International delegates will be able to review Saudi Arabia’s regulatory frameworks, manufacturing infrastructure and research capacity across the biotech value chain. - Prof. Bandar Alknawi said the summit’s theme this year is “Laying the Foundation for Excellence in Biotechnology.” - Prof. Alknawi said the summit is emphasizing structural depth this year after a previous focus on global inclusivity. - Prof. Alknawi said the summit is marking global partnerships with Harvard University in translational oncology, AstraZeneca in gene therapy and Peking University in drug discovery. - Prof. Alknawi said durable excellence depends on advanced labs, integrated research centers, clinical trial networks, biomanufacturing capacity and digital platforms. - Prof. Alknawi said building the ecosystem also requires investment in national talent, researchers, innovators and leadership development across academia, industry and regulation.

Between the lines: - The summit is being used as a policy-and-commercial showcase, not just a scientific conference. - The focus on local manufacturing, regulation and talent suggests Saudi Arabia wants to build domestic biotech capacity rather than rely only on imported expertise or technology. - The mention of flagship international partnerships signals an effort to validate the kingdom’s biotech ambitions through global names.

What’s next: - Organizers will release the full scientific program and speaker list on the summit website. - The event is expected to produce new deals, partnerships and memorandums of understanding during the three-day meeting. - Further information is available through the event website and the contact details provided by organizers.

The bottom line: - Riyadh is positioning the 2026 summit as a major milestone in Saudi Arabia’s broader biotech buildout, with investment, research and industrial capability all on the agenda.